Navari finishes first preclinical study, reaching PoC in vivo

During the last few months, Navari has been planning, designing, and coordinating activities related to their first preclinical study. During two intense weeks in the operating theater, 6 liver surgeries have been performed with the guidance of the Navari technology. The outcome from the study was great, and we are extremely happy to share that we have reached a first proof-of-concept in vivo.